Search Results

Stanford researchers have found that drug-coated nanoparticles limit the development of atherosclerosis in mice, without side effects.

Stanford data scientists have shown that figuring out a single number can help them find the most dangerous cancer cells.

Two new care areas will benefit patients with cancer, blood disorders, and heart conditions.

A new finding by Stanford researchers represents a missing link between two worlds — that of dietary science, and that of molecular and cellular biology.

A drug may help children with Pelizaeus-Merzbacher disease, a deadly neurological disorder, according to a study by researchers at Stanford, UCSF and Cambridge.

During a ceremony at the Li Ka Shing Center, first-year doctoral students marked the beginning of their graduate careers by donning white lab coats and taking an oath of integrity.

Tumors called high-grade gliomas wire themselves into the healthy brain, receiving and interpreting electrical signals from normal neurons, a Stanford study has found.

Weissman and Johns Hopkins’ Bert Vogelstein will share the 2019 Albany Medical Center Prize in Medicine and Biomedical Research for discoveries in stem cell and cancer biology.

Stanford researchers blocked a molecule to help restore neurons in rats in which the flow of fresh blood to the brain was reduced. The approach could lead to new treatments for people who have suffered a stroke or cardiac arrest.

The Stanford Microbiome Therapies Initiative is backed by gifts from Marc and Lynne Benioff and Mark and Debra Leslie and is focused on developing and testing new disease therapies.